Specific renal histopathological findings related to cardiovascular disease risk in patients with CKD

Published Date: 10 Mar 2023

Chronic renal failure (CKD) is a risk factor for cardiovascular diseases such as heart attacks, strokes or heart failure. Brigham the scientist...

Read Full News

Latest News

More Costly, Polarized Dermatoscope Results Compared to Nonpolarized Dermatoscope

More Costly, Polarized Dermatoscope Results Compared to Nonpolarized Dermatoscope

Session on the Skin Microbiome and Atopic Dermatitis Presented at 2025 SDPA Fall Conference

Session on the Skin Microbiome and Atopic Dermatitis Presented at 2025 SDPA Fall Conference

Difficult Cases and Red Flags in Dermatology, With Kassandra Holzem, MD Kassandra Holzem, MD

In her SDPA Fall Dermatology Conference interview, Holzem highlights key warning signs for a variety of dermatologic conditions requiring hospital admission.

8 Dermatology Headlines You Missed in November 2025

8 Dermatology Headlines You Missed in November 2025

Antibiotic Exposure Linked to Increased Risk of Biologic Discontinuation in Psoriasis

Antibiotic Exposure Linked to Increased Risk of Biologic Discontinuation in Psoriasis

sNDA for Ameluz-PDT as a Treatment for Superficial Basal Cell Carcinoma Submitted to FDA

sNDA for Ameluz-PDT as a Treatment for Superficial Basal Cell Carcinoma Submitted to FDA

Todays Updates

Merck’s Novel Antibody MK-2214 Receives FDA Fast-Track Designation Following Phase 1 Results Louie Pasculli

Merck's MK-2214 shows promise in early Alzheimer’s trials, earning FDA fast-track status for its safety and potential efficacy in slowing disease progression.

Dravet Syndrome Medication Stiripentol Effective in Real World Settings Across Various Patient Profiles Marco Meglio

New STIRUS data unveiled at AES 2025 demonstrate meaningful real-world reductions in seizures, status epilepticus, and healthcare needs with stiripentol in Dravet syndrome.

NBI-827104’s Phase 2 Disappointment Highlight Therapeutic Needs for Epileptic Encephalopathy With Continuous Spike-and-Wave During Sleep Marco Meglio

New findings reveal the challenges of treating pediatric epileptic encephalopathy with NBI-827104, highlighting the need for effective therapies.

5 FDA Headlines You Missed in November 2025

5 FDA Headlines You Missed in November 2025

Todays Updates

Merck’s Novel Antibody MK-2214 Receives FDA Fast-Track Designation Following Phase 1 Results Louie Pasculli

Merck's MK-2214 shows promise in early Alzheimer’s trials, earning FDA fast-track status for its safety and potential efficacy in slowing disease progression.

Dravet Syndrome Medication Stiripentol Effective in Real World Settings Across Various Patient Profiles Marco Meglio

New STIRUS data unveiled at AES 2025 demonstrate meaningful real-world reductions in seizures, status epilepticus, and healthcare needs with stiripentol in Dravet syndrome.

NBI-827104’s Phase 2 Disappointment Highlight Therapeutic Needs for Epileptic Encephalopathy With Continuous Spike-and-Wave During Sleep Marco Meglio

New findings reveal the challenges of treating pediatric epileptic encephalopathy with NBI-827104, highlighting the need for effective therapies.

5 FDA Headlines You Missed in November 2025

5 FDA Headlines You Missed in November 2025

Latest News

More Costly, Polarized Dermatoscope Results Compared to Nonpolarized Dermatoscope

Session on the Skin Microbiome and Atopic Dermatitis Presented at 2025 SDPA Fall Conference

In her SDPA Fall Dermatology Conference interview, Holzem highlights key warning signs for a variety of dermatologic conditions requiring hospital admission.

8 Dermatology Headlines You Missed in November 2025

Antibiotic Exposure Linked to Increased Risk of Biologic Discontinuation in Psoriasis

sNDA for Ameluz-PDT as a Treatment for Superficial Basal Cell Carcinoma Submitted to FDA

News All Time

Skin of Color Savvy: Hair-Care Challenges in Dermatology, With Amy McMichael, MD, and Kayla Taylor, MD Amy McMichael, MD, Kayla Taylor, MD

This November 18 episode explores early detection, diagnosis, and management of scarring alopecias and hair-care–related hair loss in patients of color.

Non-Steroidal Topicals: A Game-Changer for Pediatric Atopic Dermatitis, With Emily Becker, MD Emily Becker, MD

Becker recapped hot topics of discussion during a recent HCPLive clinical forum.

AI’s Use in Non-Patient-Facing Dermatology Spaces, With Joseph Gatti, DMSc, MPAS, MBA, PA-C

AI’s Use in Non-Patient-Facing Dermatology Spaces, With Joseph Gatti, DMSc, MPAS, MBA, PA-C

Atopic Diseases Significantly Raise the Risk of Post-Surgical Complications

Atopic Diseases Significantly Raise the Risk of Post-Surgical Complications

Discussing Zasocitinib and Other TYK2 Inhibitors for Psoriasis, With Ronald Vender, MD Ronald Vender, MD

After his sessions on TYK2 Inhibitors for psoriasis and on palmoplantar pustulosis, Vender discussed several key insights in this interview.

Progress with Emerging TYK2 Inhibitors for Psoriasis, With Benjamin Lockshin, MD Benjamin Lockshin, MD, FAAD

Benjamin Locksin speaks in this interview about his session titled ‘Encapsulating Progress With New and Emerging TYK2 Inhibitors for Psoriasis.’

Discussing Findings on Secukinumab (Cosentyx) Efficacy Over 4 Years in HS, With Martina Porter, MD Martina Porter, MD

This interview highlights long-term, phase 3 data from the SUNSHINE and SUNRISE core and extension trials on secukinumab for hidradenitis suppurativa.

Tapinarof Shows Early, Sustained Benefits in Pediatric Atopic Dermatitis, With Druhan Howell, MD Druhan Howell, MD

At ACAAI 2025, Howell discussed sub-analytical data showing early itch and skin improvements with tapinarof cream in children with AD aged 2–17 years.

ARCADIA LTE: Long-term Nemolizumab Effective in Adolescents with Atopic Dermatitis

ARCADIA LTE: Long-term Nemolizumab Effective in Adolescents with Atopic Dermatitis

Skin of Color Savvy: A New Podcast Episode Following SOCS Media Day

Skin of Color Savvy: A New Podcast Episode Following SOCS Media Day

The HCPFive: Top News for Healthcare Providers from the Week of 11/16

The HCPFive: Top News for Healthcare Providers from the Week of 11/16

Durability of Biologics for Psoriasis Compared, Adjusted for Drug Switching Over Time

Durability of Biologics for Psoriasis Compared, Adjusted for Drug Switching Over Time

Mid Trial Update Released on Baricitinib for Frontal Fibrosing Alopecia

Mid Trial Update Released on Baricitinib for Frontal Fibrosing Alopecia

Rezpegaldesleukin Shows Strong Phase 2b Results for Atopic Dermatitis, Asthma

Rezpegaldesleukin Shows Strong Phase 2b Results for Atopic Dermatitis, Asthma

New 'heart percentile' calculator helps young adults grasp their long-term risk

A new Northwestern Medicine study introduces a first-of-its-kind online calculator that uses percentiles to help younger adults forecast and understand their risk of a heart event over the next 30 years. With rates of obesity, ...

Chronic pain may increase risk of high blood pressure in adults

Chronic pain in adults may increase their risk of high blood pressure, and the location and extent of pain and if they also had depression were contributing factors, according to new research published today in Hypertension.

Recommended News For You

Having dense breasts is linked to cancer, but advice about breast density can depend on where you live

Hereditary cancer has a rare and underreported cause.

Report suggests a big improvement in lung cancer survival

Algorithm that predicts pancreatic cancer metastasis could help avoid unnecessary surgeries

Modified personalized cancer vaccine generates powerful immune response

The September 2018 issue of Medical Bulletin.

Chemotherapy before surgery helps patients with nose and sinus cancer avoid debilitating eye and bone removal

Recommended Articles For You

Revolutionizing Cancer Treatment with Darzalex: How an Innovative Drug is Transforming Lives 

The Mystery of Carotid Body Tumors: The Facts You Need to Know 

Understanding Blood Dyscrasia: Symptoms, Causes and Treatment Options 

Oncology Drug Trends 2025: FDA Approvals, Immuno-Oncology, and Clinical Trial Insights 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Data-driven risk stratification guides childhood brain tumor treatment, reducing side effects

2.

Early cancer detection during pregnancy and the postpartum period may be aided by breast milk examination.

3.

Five new papers highlight cancer inequities, challenges and opportunities in South Asia

4.

Colorectal Cancer Screening Uptake Tripled in 45-49 Age Group

5.

Report suggests a big improvement in lung cancer survival

1.

Getting to Know RDW and SD: How They Relate to Anemia, Inflammation, and More 

2.

Don't Ignore Your Vision Loss: What You Need to Know About Amaurosis Fugax 

3.

Understanding Fibrosarcoma: What You Need to Know 

4.

Unlocking the Mystery of Leukemia: Exploring New Treatments and Hope for Patients

5.

Gene Signatures and Their Implications in Oncology: Decoding the Blueprint for Personalized Cancer Treatment

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part II

2.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VI

3.

Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option

4.

The Reign of the CROWN Trial and the Dawn of a New Era in Frontline Management- Further Discussion

5.

Summary of The Impact of CDK4/6 Inhibition in HR+/HER2- Metastatic Breast Cancer: Insights from PALOMA-2

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot